193 related articles for article (PubMed ID: 12874899)
1. [Carcinoids of the gastrointestinal tract: importance of determining differentiation and proliferation markers].
Jirásek T; Mandys V
Cesk Patol; 2003 Apr; 39(2):47-53. PubMed ID: 12874899
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
3. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
[TBL] [Abstract][Full Text] [Related]
5. Primary renal carcinoid. Case report and literature review.
Goldblum JR; Lloyd RV
Arch Pathol Lab Med; 1993 Aug; 117(8):855-8. PubMed ID: 7688215
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.
Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y
Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Vyberg M; Horn T; Francis D; Askaa J
Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity.
Moyana TN; Xiang J; Senthilselvan A; Kulaga A
Arch Pathol Lab Med; 2000 Apr; 124(4):570-6. PubMed ID: 10747315
[TBL] [Abstract][Full Text] [Related]
11. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
12. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Rasmuson T; Grankvist K; Roos G; Ljungberg B
Acta Oncol; 1999; 38(5):623-8. PubMed ID: 10427952
[TBL] [Abstract][Full Text] [Related]
14. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD
Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
17. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.
Ather MH; Abbas F; Faruqui N; Israr M; Pervez S
BMC Urol; 2008 Dec; 8():21. PubMed ID: 19115997
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.
Schürmann G; Betzler M; Buhr HJ
Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326
[TBL] [Abstract][Full Text] [Related]
19. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of the alpha subunit of a guanine nucleotide-binding protein (Go) in pulmonary neuroendocrine cells and neoplasms.
Kawano N; Ito T; Kitamura H; Shibagaki T; Kameda Y; Nakamura N; Kanisawa M
Pathol Int; 1996 Jun; 46(6):393-8. PubMed ID: 8869990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
